Sensitivity analyses adjusting for all potential influencing factors showed that the identified associations of CSF complement proteins with cognition, AD pathology, and brain structures barely changed, and only the non-significant associations of CSF C2 and C5 with aggravated tau pathology in the MCI group turned significant (Additional file 1: Table S7-8). The gene discussed is MAPT; the disease is Alzheimer disease.